Balyasny Asset Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,322	Closed	-$57.3K	–	2339
2024 Q1	$57.3K	Buy	+12,322	New	+$57.3K	﹤0.01%	1902
2022 Q4	–	Sell	-307,314	Closed	-$11.4M	–	2678
2022 Q3	$11.4M	Buy	307,314 +68,793	+29%	+$2.55M	0.03%	513
2022 Q2	$4.53M	Buy	+238,521	New	+$4.53M	0.01%	798